Abbott Laboratories will pay more than $384 million to states and the federal government, including more than $9.3 million to New York.

The recall covered several infant formula brands, including Similac.

The U.S. Department of Justice alleged manufacturing conditions at Abbott’s Sturgis, Mich., facility put infant formula at ...

Abbott recalled its infant formula products and closed its Michigan plant in 2022 after investigators found traces of a ...

Michigan will receive a chunk of the U.S. Justice Department's $385 million settlement with Abbott Laboratories over ...

Abbott has agreed to pay $385 million to resolve allegations that it supplied formula that did not meet required safety and manufacturing standards.

The settlement resolves a case by the federal government related to allegations about false claims and is not a determination of liability on the part of the company.

Abbott will pay $384,999,040 to settle civil allegations about infant formula made in Michigan and Arizona. The company denies wrongdoing.

Abbott Laboratories will pay over $384M after selling baby formula from taxpayer-funded programs in unsafe conditions, with Oregon receiving close to $1M from the settlement.

The settlement resolves a lawsuit originally brought by three former Abbott employees under whistleblower protections.

Abbott trades at a cheaper valuation but carries higher litigation risk, while J&J boasts superior profitability despite a pending talc settlement.